80 related articles for article (PubMed ID: 11077884)
1. Thiazolidinediones--a means to endpoint intervention.
Jerkins TW
Tenn Med; 2000 Nov; 93(11):403-5. PubMed ID: 11077884
[No Abstract] [Full Text] [Related]
2. Are thiazolidinediones first-line agents?
Weldy DL
J Fam Pract; 2002 Nov; 51(11):984; author reply 984. PubMed ID: 12485560
[No Abstract] [Full Text] [Related]
3. [Early effect of therapy with pioglitazone. Vascular damage significantly reduced].
MMW Fortschr Med; 2002 May; 144(21):53. PubMed ID: 12134428
[No Abstract] [Full Text] [Related]
4. [Thiazolidindiones in type II diabetes mellitus].
Bornkessel B
Med Monatsschr Pharm; 1998 Mar; 21(3):66-8. PubMed ID: 9556974
[No Abstract] [Full Text] [Related]
5. [Prevention of arteriosclerosis with the insulin sensitizer pioglitazone. Early intervention in diabetic patients compensates "cell ignorance"].
MMW Fortschr Med; 2002 May; 144(21):52-3. PubMed ID: 12134427
[No Abstract] [Full Text] [Related]
6. Management of type 2 diabetes mellitus.
Murphy MB; Kitabchi AE
Tenn Med; 2000 Nov; 93(11):398-402. PubMed ID: 11077883
[No Abstract] [Full Text] [Related]
7. Beneficial hepatic effect of troglitazone in a patient with antimitochondrial antibody-negative primary biliary cirrhosis.
Okai T; Mouri H; Yamaguchi Y; Nakanuma Y; Sawabu N
Am J Gastroenterol; 2002 Jan; 97(1):209-10. PubMed ID: 11808957
[No Abstract] [Full Text] [Related]
8. Troglitazone: a new drug for type 2 diabetes mellitus.
Deb P; Bhatia E
Natl Med J India; 1998; 11(2):81-2. PubMed ID: 9624868
[No Abstract] [Full Text] [Related]
9. [30-year-old diabetic patients mostly have type 2 diabetes. "Mature" diabetics are becoming increasingly younger].
MMW Fortschr Med; 2001 Jan; 143(4):46. PubMed ID: 11219286
[No Abstract] [Full Text] [Related]
10. Combination agents for diabetes.
Samuel J; Rochester CD
Adv Nurse Pract; 2003 Jun; 11(6):22-4. PubMed ID: 12807051
[No Abstract] [Full Text] [Related]
11. [Thiazolidinediones--new antidiabetic agents. Why don't we know how to use them?].
Gale EA
Ugeskr Laeger; 2001 Dec; 163(50):7032-5. PubMed ID: 11794032
[No Abstract] [Full Text] [Related]
12. [Metformin. Mode of action and effect of monotherapy and combination therapy on glucose metabolism in type 2 diabetes].
Christiansen AL; Madsbad S
Ugeskr Laeger; 2002 Apr; 164(15):2025-8. PubMed ID: 11985000
[TBL] [Abstract][Full Text] [Related]
13. [Primary prevention of diabetes mellitus by pharmacological intervention].
Noda M
Nihon Rinsho; 2002 Sep; 60 Suppl 9():100-8. PubMed ID: 12386980
[No Abstract] [Full Text] [Related]
14. Rosiglitazone reduces urinary albumin excretion in type II diabetes.
Bakris G; Viberti G; Weston WM; Heise M; Porter LE; Freed MI
J Hum Hypertens; 2003 Jan; 17(1):7-12. PubMed ID: 12571611
[TBL] [Abstract][Full Text] [Related]
15. [Glitazones--a new therapeutic principle in diabetes].
Birkeland KI
Tidsskr Nor Laegeforen; 2001 Sep; 121(22):2617-9. PubMed ID: 11668762
[No Abstract] [Full Text] [Related]
16. [World news in age-related diabetes: blood sugar lowering can improve prognosis].
Einecke D
MMW Fortschr Med; 2005 Sep; 147(38):1. PubMed ID: 16218218
[No Abstract] [Full Text] [Related]
17. [Infarct prevention for diabetics. To lower blood sugar is not enough].
MMW Fortschr Med; 2001 Nov; 143(46):61. PubMed ID: 11759608
[No Abstract] [Full Text] [Related]
18. [The effect of glitazones on the progression of type 2 diabetes and on cardiovascular endpoints].
Schatz H
Dtsch Med Wochenschr; 2005 Aug; 130(31-32):1825-30. PubMed ID: 16052448
[No Abstract] [Full Text] [Related]
19. Rational choice of oral antihyperglycaemic agents.
Chowdhury S; Sengupta N
J Indian Med Assoc; 2002 Mar; 100(3):174-5, 177. PubMed ID: 12408278
[TBL] [Abstract][Full Text] [Related]
20. Optimizing treatment for patients with diabetes mellitus: glycemic and nonglycemic effects.
Shubrook JH
J Am Osteopath Assoc; 2011 Jul; 111(7 Suppl 5):Sii-1. PubMed ID: 21928545
[No Abstract] [Full Text] [Related]
[Next] [New Search]
